Company Profile

# MEDICAMEN BIOTECH LIMITED HAS 3 STATE OF THE ART PLANT FOR PHARMACEUTICAL FORMULATIONS MANUFACTURING INCLUDING DEDICATED ONCOLOGY PLANT FOR INJECTABLES , TABLETS , CAPSULES . THIS PLANT HAS UNDERGONE SUCCSESFUL USFDA AUDIT FOR INJECTABLES AND APPROVAL EXPECTED IN AUGUST 2024 , MEDICAMEN IS ALSO AUDITED FOR EU GMP FROM GREECE IN MAY 2024 AND APPROVAL EXPECTED IN AUGUST 2024 FOR GENERAL TABLETS AND LIQUID ORALS COMPNAY IS MAINLY INTO EXPORTS TO MORE THAN 35 COUNTRIES AND ALSO HAS DOMESTIC MARKETING OF ONCOLOGY FORMULATIONS PAN INDIA